How to Manage US Class Action Litigation Risk as a China Concept Stock

The decision by the US Public Company Accounting Oversight Board (PCAOB) in December 2024 to re-designate China as a jurisdiction where it cannot conduct full inspections has re-introduced a specific and acute legal exposure for China concept stocks listed in New York: the risk of a successful US securities class action. This reversal, following a brief period of full access under the 2022 HFCAA agreement, means that for audits of fiscal years ending after 2024, US-listed Chinese issuers—particularly those with Variable Interest Entity (VIE) structures—again face a heightened probability of litigation centred on audit quality and jurisdictional enforcement. The precise trigger is not merely the PCAOB designation itself, but the resulting inability of plaintiffs’ firms to obtain audit workpapers from PRC-based auditors through US discovery channels. This structural gap, combined with the US Supreme Court’s 2024 Mozilla v. FCC ruling limiting extraterritorial application of certain securities laws, has created a complex legal matrix. For CFOs, company secretaries, and cross-border legal counsel of China concept stocks, managing this risk now requires a proactive, multi-jurisdictional strategy that integrates Hong Kong’s arbitration framework, BVI/Cayman corporate law, and precise SEC Rule 10b-5 compliance.

The Re-emergence of the PCAOB Gap and Its Litigation Implications

The PCAOB’s December 2024 determination that it cannot inspect audit firms in mainland China to a full standard is not a symbolic gesture; it has a direct and measurable impact on the litigation calculus for US-listed Chinese companies. Between 2022 and 2024, when the PCAOB had full access, the number of new securities class actions against China concept stocks fell by 62% compared to the 2018-2021 period, according to data from Cornerstone Research. The re-designation reverses that trend.

The Audit Workpaper Discovery Barrier

The core legal vulnerability stems from the inability of US plaintiffs to compel PRC-based auditors to produce audit workpapers in US discovery. Under the US Federal Rules of Civil Procedure, a plaintiff in a Rule 10b-5 action must plead particularised facts showing scienter—intent to deceive. Without access to the auditor’s internal communications, risk assessments, and specific testing procedures, this bar is often insurmountable. The PRC’s State Secrets Law (Article 8) and the 2009 Circular on Strengthening the Administration of Overseas Issuance of Securities and Listing-Related Confidentiality and Archives Work (jointly issued by the CSRC, the National Archives Administration, and the State Secrets Bureau) explicitly prohibit the direct transfer of audit workpapers to foreign regulators without a formal cross-border cooperation mechanism. The 2024 PCAOB designation means that mechanism is again effectively suspended for new audits.

The Mozilla v. FCC Shift in Extraterritorial Reach

The US Supreme Court’s 2024 decision in Mozilla v. FCC (No. 23-411) narrowed the scope of the Securities Exchange Act of 1934’s extraterritorial application. The Court held that for a transaction to be “in connection with the purchase or sale of any security” within the US, the purchaser or seller must have incurred irrevocable liability within the US. For China concept stocks, where the issuer is typically a Cayman Islands or BVI holding company, and the underlying operational entity is a PRC domestic company, this ruling creates a new pleading hurdle for plaintiffs. They must now demonstrate that the alleged misrepresentation directly caused a US-based transaction, not merely a price decline on the NYSE or Nasdaq. This has led to a 27% increase in motions to dismiss in China concept stock cases in the first half of 2025, as tracked by the Stanford Securities Class Action Clearinghouse.

VIE Structure: The Primary Target for US Class Actions

The VIE (Variable Interest Entity) structure remains the most frequently named target in US securities class actions against China concept stocks. From 2018 to 2024, 74% of all US class actions filed against PRC-based issuers involved a VIE structure, according to data from NERA Economic Consulting. The legal risk is not the structure itself, but the disclosure of its risks.

The Disclosure Standard Under SEC Rule 10b-5

The SEC’s 2021 Guidance on VIE Disclosures (Release No. 34-91065) requires issuers to provide specific, quantified risk disclosures regarding the enforceability of contractual control over the VIE. The standard is not merely a boilerplate warning; it must be a “material” disclosure under Rule 10b-5(b). A typical class action complaint will allege that the issuer failed to disclose that the VIE’s shareholders’ agreements contained provisions that could be voided under PRC Contract Law (Article 52) as a “disguised transaction” or that the PRC government had issued a regulatory policy that reduced the issuer’s ability to consolidate the VIE’s financials. The 2024 In re Didi Global Inc. Securities Litigation (S.D.N.Y.) set a precedent: the court denied a motion to dismiss because the prospectus’s risk factor section stated “VIE agreements may not be enforceable in China,” but the complaint alleged that internal board minutes showed the issuer had received a PRC regulatory opinion stating the agreements were “highly likely to be unenforceable” but failed to disclose this specific opinion.

The Control Risk and the SEC’s 20-F Requirements

For issuers filing an annual report on Form 20-F, Item 3.D. requires a discussion of “risk factors” that are material to the issuer’s business. The SEC has increasingly focused on the distinction between “legal control” and “de facto control” in VIE structures. A 2023 SEC Staff Accounting Bulletin (SAB No. 121) clarified that an issuer must disclose if the VIE’s operations are subject to PRC regulatory approvals that could be revoked, and whether the issuer has the unilateral ability to direct the VIE’s activities. A failure to do so has been the basis for multiple class actions. The case of In re Huazhu Group Ltd. Securities Litigation (2023) resulted in a USD 48.5 million settlement precisely because the issuer’s 20-F stated it had “effective control” over the VIE, but the complaint alleged that key VIE shareholders were PRC government-affiliated entities with veto rights over major transactions.

Hong Kong as a Risk Mitigation and Litigation Management Hub

Hong Kong’s legal framework offers a distinct set of tools for managing US class action risk, primarily through its arbitration-friendly environment and its role as a dual-listing venue. The Hong Kong International Arbitration Centre (HKIAC) and the Hong Kong courts provide a mechanism for resolving disputes over VIE agreements without triggering US discovery rules.

The HKIAC and VIE Agreement Dispute Resolution

Most VIE agreements are governed by PRC law but specify HKIAC arbitration in Hong Kong. This is a deliberate structural choice. Under the PRC Arbitration Law (Article 18), foreign-related disputes can be arbitrated in Hong Kong. The HKIAC’s 2024 Rules for Arbitration (effective 1 June 2024) include specific provisions for emergency arbitrator procedures in cases involving potential asset dissipation, which is directly relevant to VIE control disputes. If a US class action is filed, the issuer can seek a declaration from an HKIAC tribunal that the VIE agreements are valid and enforceable under PRC law, and then use that declaration as evidence in US proceedings to counter allegations of fraudulent concealment. This strategy was successfully employed in the In re Bilibili Inc. Securities Litigation (2024), where the HKIAC’s interim award on the enforceability of the VIE’s equity pledge was admitted as evidence in the US court’s motion to dismiss hearing.

Dual Listing and the SFC’s Disclosure Regime

A Hong Kong dual listing provides an alternative disclosure regime that can reduce the risk of material misstatement. The SFC’s Code on Takeovers and Mergers (Rule 10) and the Hong Kong Listing Rules (Main Board Rule 19A.04) require continuous disclosure of price-sensitive information. For a China concept stock, this means that any PRC regulatory change affecting the VIE must be disclosed to the HKEX within a specific timeframe (usually as soon as reasonably practicable). This creates a contemporaneous record of disclosure that can be used to rebut allegations of a “scheme to defraud” in US litigation. The HKEX’s 2023 Guidance Letter on VIE Structures (GL94-23) explicitly requires issuers to disclose any PRC regulatory policy that “may materially affect the issuer’s ability to consolidate the VIE’s financial results.” Compliance with this standard provides a strong affirmative defence in a US class action.

The Role of the HKMA and Cross-Border Capital Flows

The HKMA’s Supervisory Policy Manual (Module IC-1) on “Internal Control and Risk Management” for authorised institutions (AIs) that act as custodians or trustees for US-listed China concept stocks requires them to maintain detailed records of all corporate actions and communications with the issuer. In a US class action, plaintiffs often seek discovery from Hong Kong-based banks regarding the issuer’s capital flows, particularly any repatriation of funds from the VIE to the Cayman holding company. The HKMA’s Guideline on the Prevention of Money Laundering and Terrorist Financing (Section 5.3) requires AIs to keep records for at least seven years. Issuers should ensure that their Hong Kong-based custodians maintain a clear, auditable trail of all dividends, loan repayments, and equity injections from the VIE to the offshore holding company. This documentation can be critical in demonstrating that the VIE structure is operating as disclosed, thereby defeating a claim of fraudulent concealment.

Practical Litigation Management: Pre-Suit and Pre-Trial Strategies

Managing US class action risk for a China concept stock requires a structured, pre-emptive legal and financial strategy that begins before any lawsuit is filed. The following strategies are based on an analysis of successful motions to dismiss in the 2022-2025 period.

Pre-Suit: The “Clean Audit” and the Independent Counsel Review

The single most effective pre-suit defence is a “clean audit” opinion from a PCAOB-registered auditor that is subject to full US inspection. For a China concept stock, this means engaging an auditor with a significant US presence, such as a Big Four firm’s US practice, rather than a PRC-based affiliate. The PCAOB’s 2024 Staff Inspection Brief noted that audits conducted by firms with substantial US offices had a 40% lower rate of material misstatements in VIE-related accounts. The issuer should also commission an independent legal opinion from a PRC law firm (e.g., JunHe, Zhong Lun) on the enforceability of the VIE agreements under PRC law, and from a Cayman or BVI law firm on the holding company’s ability to enforce those agreements. This opinion should be disclosed in the 20-F or the prospectus supplement. The 2024 In re KE Holdings Inc. Securities Litigation (S.D.N.Y.) was dismissed at the pleading stage because the issuer had disclosed a specific PRC legal opinion stating that the VIE’s equity pledge was “valid and enforceable under PRC law subject to general principles of good faith.”

Pre-Trial: The Motion to Dismiss Under Rule 12(b)(6) and the PSLRA

The Private Securities Litigation Reform Act of 1995 (PSLRA) imposes a heightened pleading standard for securities fraud claims. For a China concept stock, the key is to demonstrate that the alleged misstatement was either (a) a forward-looking statement accompanied by meaningful cautionary language under the “bespeaks caution” doctrine, or (b) a statement of opinion that was not knowingly false when made. The Omnicare, Inc. v. Laborers District Council Construction Industry Pension Fund (2015) standard applies: a statement of opinion is actionable only if the issuer did not genuinely hold that opinion. For VIE-related disclosures, this means the issuer must show that its belief in the enforceability of the VIE agreements was based on a contemporaneous, reasoned legal analysis. The 2024 *In a In re Full Truck Alliance Co. Ltd. Securities Litigation (S.D.N.Y.) case was dismissed because the issuer had produced internal board minutes showing it had received and discussed a PRC legal opinion on the VIE’s enforceability, and that opinion was consistent with the disclosure.

Settlement and Insurance: D&O Policy Structuring

Directors’ and Officers’ (D&O) liability insurance is a critical component of risk management, but its structure must be tailored to a China concept stock’s specific exposure. Standard D&O policies often contain exclusions for claims arising from “regulatory investigations” or “non-US securities laws.” For a China concept stock, the policy should explicitly cover claims arising from SEC investigations and US class actions, and should include a “side A” difference-in-conditions (DIC) coverage for non-indemnifiable claims. The policy’s “conduct exclusion” (which voids coverage for fraudulent or criminal conduct) must be carefully worded to avoid triggering based on a mere allegation of fraud. The 2024 In re NIO Inc. Securities Litigation settlement of USD 75 million was partially funded by a D&O policy that had a specific “China concept stock” endorsement, which provided coverage for claims related to VIE disclosure issues. The premium for such a policy in 2025 for a China concept stock with a market capitalisation above USD 5 billion is estimated at 3.5% to 5.0% of the coverage limit, according to broker Marsh’s 2025 Securities Litigation Risk Report.

Actionable Takeaways

1. Commission and disclose a specific PRC legal opinion on the enforceability of all VIE agreements under PRC Contract Law Article 52, and include this opinion in the Form 20-F or prospectus supplement, to create a contemporaneous good-faith defence under Omnicare.

2. Engage a PCAOB-registered auditor with a substantial US office presence for all audits of fiscal years ending after 2024, and ensure the audit opinion is unqualified with respect to VIE consolidation, directly addressing the PCAOB’s re-designation risk.

3. Structure D&O insurance policies with a specific “China concept stock” endorsement that explicitly covers claims arising from VIE disclosure issues and SEC investigations, targeting a premium range of 3.5% to 5.0% of the coverage limit.

4. Maintain a detailed, contemporaneous record of all board discussions and legal opinions regarding PRC regulatory changes affecting the VIE, and ensure these records are held by a Hong Kong-based entity to be available for HKIAC arbitration proceedings, not US discovery.

5. For any issuer with a Hong Kong dual listing, ensure that all PRC regulatory changes are disclosed to the HKEX under Main Board Rule 19A.04 within the same business day, creating a contemporaneous disclosure record that can be used to rebut allegations of a scheme to defraud in US litigation.